TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,156,045
|
3,564,331
|
2,930,547 |
| Earnings before taxes |
476,648
|
1,087,801
|
984,512 |
| Total assets |
5,465,294
|
4,868,654
|
4,212,230 |
| Current assets |
1,807,936
|
2,054,643
|
2,833,193 |
| Current liabilities |
3,288,822
|
2,745,173
|
2,524,971 |
| Equity capital |
463,666
|
936,066
|
849,759 |
| - share capital |
64,632
|
60,660
|
57,474 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.5%
|
19.2%
|
20.2% |
| Turnover per employee |
9,017
|
10,184
|
8,373 |
| Profit as a percentage of turnover |
15.1%
|
30.5%
|
33.6% |
| Return on assets (ROA) | |||
| Current ratio |
55.0%
|
74.8%
|
112.2% |
| Return on equity (ROE) |
102.8%
|
116.2%
|
115.9% |
| Change turnover |
-641,643
|
471,323
|
979,019 |
| Change turnover % |
-17%
|
15%
|
50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.